Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Scisco Genetics is a private Seattle-based immunogenetics company that provides next-generation sequencing-based genotyping services, assay kits, and software for complex immune gene systems. Its commercial offerings focus on high-resolution typing of HLA, KIR, MICA/MICB, Fc gamma receptor, IGHG, chimerism, and related targeted variation applications used in transplantation, immunology, and research settings. The company markets ScisGo assay kits and ScisCloud analysis and workflow software built around Illumina MiSeq sequencing workflows. Scisco Genetics positions its platform around highly accurate, phased typing and data interpretation for clinical and research laboratories. It appears to operate as a specialized diagnostics and research-tools company rather than a therapeutic drug developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Scisco Genetics.